Posts Tagged ‘Ergéa’
Leadership Changes at Ergéa Group
Ergéa Group appoints Dr. Michael Thorwarth as Group CEO; Dr. Guglielmo Brayda di Soleto transitions to Co-Chairman of Ergéa Group. As of September 16th 2024, Dr. Michael Thorwarth, currently CEO of Ergéa Deutschland, has been appointed as the new Group CEO. He will continue and expand Ergéa’s collaborative leadership model and work in partnership with…
Read MoreErgéa Germany appoints new Head of Clinical Services
The CEO of our German entity, RadioOnkologieNetzwerk, Dr. Michael Thorwarth, alongside with the CCO of RadioOnkologieNetzwerk, Johannes Schröder, has given a warm welcome to Jens Ower, as he assumes the newly established role as Head of Business Unit Clinical Services. Jens’ appointment marks a significant milestone in expanding Ergéa Group’s services in Germany. Drawing upon…
Read MoreChanges in Leadership: Ergéa Deutschland’s Transition
Ergéa Deutschland appoints Dr. Michael Thorwarth as CEO and Johannes Schröder as CCO; co-founders and CEOs Dr. Sandra Röddiger and Dr. Ralf Kurek transition to Co-Chairpersons at Ergéa Group. Co-founders of RadioOnkologieNetwerk and CEOs of Ergéa Deutschland, Dr. Sandra Röddiger and Dr. Ralf Kurek, have transitioned to new roles as Co-Chairpersons of the Board of…
Read MoreErgéa Group strengthens the Senior Team with Head of Supplier Relationships and Head of International Projects
We are pleased to announce the appointment of two key positions in our senior team: Brendan Loughran joins Ergéa Group as Head of Supplier Relationships, and Jason Long takes on the role of Head of International projects at Ergéa Group. Both appointments are effective as of May 2023. As Head of Supplier Relationships, Brendan Loughran,…
Read MoreErgéa Group establishes Medical Scientific Committee to drive innovation and enhance quality
Ergéa Group proudly announces the formation of its new Medical Scientific Committee, a diverse and experienced team of experts in oncology, radiation therapy, radiology, nuclear medicine, clinical engineering and technology assessment. The Medical Scientific Committee will convene on a regular basis to provide responses to any questions arising from the group’s activities, with a strong…
Read More